Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

149 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The NCI60 human tumour cell line anticancer drug screen.
Shoemaker RH. Shoemaker RH. Nat Rev Cancer. 2006 Oct;6(10):813-23. doi: 10.1038/nrc1951. Nat Rev Cancer. 2006. PMID: 16990858 Review.
Vincristine induction of mutant and wild-type human multidrug-resistance promoters is cell-type-specific and dose-dependent.
Stein U, Walther W, Shoemaker RH. Stein U, et al. Among authors: shoemaker rh. J Cancer Res Clin Oncol. 1996;122(5):275-82. doi: 10.1007/BF01261403. J Cancer Res Clin Oncol. 1996. PMID: 8609150
Feasibility of cellular microencapsulation technology for evaluation of anti-human immunodeficiency virus drugs in vivo.
McMahon J, Schmid S, Weislow O, Stinson S, Camalier R, Gulakowski R, Shoemaker R, Kiser R, Dykes D, Harrison S, et al. McMahon J, et al. J Natl Cancer Inst. 1990 Nov 21;82(22):1761-5. doi: 10.1093/jnci/82.22.1761. J Natl Cancer Inst. 1990. PMID: 2231771
Microencapsulated tumor assay: new short-term assay for in vivo evaluation of the effects of anticancer drugs on human tumor cell lines.
Gorelik E, Ovejera A, Shoemaker R, Jarvis A, Alley M, Duff R, Mayo J, Herberman R, Boyd M. Gorelik E, et al. Cancer Res. 1987 Nov 1;47(21):5739-47. Cancer Res. 1987. PMID: 3664478
A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
Vickers PJ, Dickson RB, Shoemaker R, Cowan KH. Vickers PJ, et al. Mol Endocrinol. 1988 Oct;2(10):886-92. doi: 10.1210/mend-2-10-886. Mol Endocrinol. 1988. PMID: 3185565
Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.
Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, et al. Monks A, et al. J Natl Cancer Inst. 1991 Jun 5;83(11):757-66. doi: 10.1093/jnci/83.11.757. J Natl Cancer Inst. 1991. PMID: 2041050
Metastasis models for human tumors in athymic mice: useful models for drug development.
Fine DL, Shoemaker R, Gazdar A, Mayo JG, Fodstad O, Boyd MR, Abbott BJ, Donovan PA. Fine DL, et al. Cancer Detect Prev Suppl. 1987;1:291-9. Cancer Detect Prev Suppl. 1987. PMID: 3480056
Phase I trial of dihydrolenperone in lung cancer patients: a novel compound with in vitro activity against lung cancer.
Johnson BE, Parker R, Tsai CM, Baltz J, Miller MJ, Shoemaker R, Phelps R, Bastian A, Stocker J, Phares J, et al. Johnson BE, et al. Invest New Drugs. 1993 Feb;11(1):29-37. doi: 10.1007/BF00873907. Invest New Drugs. 1993. PMID: 8349433 Clinical Trial.
A potential role for imaging technology in anticancer efficacy evaluations.
Hollingshead MG, Bonomi CA, Borgel SD, Carter JP, Shoemaker R, Melillo G, Sausville EA. Hollingshead MG, et al. Eur J Cancer. 2004 Apr;40(6):890-8. doi: 10.1016/j.ejca.2003.12.018. Eur J Cancer. 2004. PMID: 15120044
In vivo models for experimental therapeutics relevant to human cancer.
Gitler MS, Sausville EA, Hollingshead M, Shoemaker R. Gitler MS, et al. Cancer Res. 2004 Nov 15;64(22):8478-80. doi: 10.1158/0008-5472.CAN-04-2057. Cancer Res. 2004. PMID: 15548722 No abstract available.
149 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page